These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16877377)

  • 1. Timing of FSH administration for ovarian stimulation in normo-ovulatory women: comparison of an early or a mid follicular phase initiation of a short-term treatment.
    Cedrin-Durnerin I; Massin N; Galey-Fontaine J; Bry-Gauillard H; Roger M; Lahlou N; Hugues JN
    Hum Reprod; 2006 Nov; 21(11):2941-7. PubMed ID: 16877377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women.
    Hohmann FP; Laven JS; de Jong FH; Fauser BC
    Eur J Endocrinol; 2005 Mar; 152(3):395-401. PubMed ID: 15757856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I; Hop WC; Fauser BC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P; Fauser BC; Platteau P; Beckers NG; Dhont M; Mannaerts BM
    J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development.
    Hohmann FP; Laven JS; de Jong FH; Eijkemans MJ; Fauser BC
    Hum Reprod; 2001 May; 16(5):846-54. PubMed ID: 11331627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results with early follicular phase recombinant luteinizing hormone supplementation during stimulation for in vitro fertilization.
    Kovacs P; Kovats T; Kaali SG
    Fertil Steril; 2010 Feb; 93(2):475-9. PubMed ID: 19200991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early follicle development alters the relationship between antral follicle counts and inhibin B and follicle-stimulating hormone levels on cycle day 3.
    Grynberg M; Feyereisen E; Scheffer JB; Koutroubis P; Frydman R; Fanchin R
    Fertil Steril; 2010 Feb; 93(3):894-9. PubMed ID: 19061996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential.
    Balasch J; Fábregues F; Creus M; Peñarrubia J; Vidal E; Carmona F; Puerto B; Vanrell JA
    J Assist Reprod Genet; 2000 Jan; 17(1):20-7. PubMed ID: 10754779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC; Alper MM; Ledger W; Schoolcraft WB; Zandvliet A; Mannaerts BM;
    Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of recombinant equine follicle stimulating hormone (reFSH) to promote follicular growth in mares using a follicular suppression model.
    Jennings MW; Boime I; Daphna-Iken D; Jablonka-Shariff A; Conley AJ; Colgin M; Bidstrup LA; Meyers-Brown GA; Famula TR; Roser JF
    Anim Reprod Sci; 2009 Dec; 116(3-4):291-307. PubMed ID: 19237253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation?
    Caserta D; Lisi F; Marci R; Ciardo F; Fazi A; Lisi R; Moscarini M
    Gynecol Endocrinol; 2011 Nov; 27(11):862-6. PubMed ID: 21391759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5.
    Blockeel C; Sterrenburg MD; Broekmans FJ; Eijkemans MJ; Smitz J; Devroey P; Fauser BC
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1122-8. PubMed ID: 21307142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
    Gomes MK; Vieira CS; Moura MD; Manetta LA; Leite SP; Reis RM; Ferriani RA
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
    Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
    Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the follicle-stimulating hormone (FSH) threshold for initiating the final stages of follicular development in women with elevated FSH levels in the early follicular phase.
    de Koning CH; Schoemaker J; Lambalk CB
    Fertil Steril; 2004 Sep; 82(3):650-3. PubMed ID: 15374709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of follicular development in high fecundity Olkuska ewes during the estrous cycle.
    Zieba DA; Murawski M; Schwarz T; Wierzchos E
    Reprod Biol; 2002 Mar; 2(1):39-58. PubMed ID: 14666161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.
    Sullivan MW; Stewart-Akers A; Krasnow JS; Berga SL; Zeleznik AJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):228-32. PubMed ID: 9920089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.